Back to Trades
Sell4
Kiniksa Pharmaceuticals International, plc
KNSA
Total Value
$580.6K
Net $465.8K sold
Sales
$465.8K
2 transactions
Company Information
- Company Name
- Kiniksa Pharmaceuticals International, plc
- Ticker Symbol
- KNSA
- CIK
- 0001730430
Insider Information
- Name
- Tessari Eben
- Role
- Insider
- Location
- LONDON, X0
Filing Details
- Filing Date
- Oct 16, 2025
- Transaction Date
- Oct 14, 2025
- Accession Number
- 0001867899-25-000007
- Form Type
- 4
- Net Trading Amount
- -$465.8K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Oct 14, 2025 | Class A Ordinary Share | 6,500 | $8.83 | Exercise | $57.4K |
| Oct 14, 2025 | Class A Ordinary Share | 11,815 | $37.65 | Sale | $444.8K |
| Oct 14, 2025 | Class A Ordinary Share | 553 | $37.99 | Sale | $21.0K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Oct 14, 2025 | Derivative | 6,500 | $8.83 | Exercise | $57.4K |
Footnotes
- (F1)This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 29, 2024.
- (F2)This transaction was executed in multiple trades through a broker-dealer at prices ranging between $36.98 and $37.97. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- (F3)This transaction was executed in multiple trades through a broker-dealer at prices ranging between $37.98 and $38.00. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- (F4)The option is fully vested and exercisable.